Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
about
Declines in levels of hyperpolarization-activated cation (HCN) channels in the rat ovary after cisplatin exposurePotential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats.Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuriaThe association of transporter genes polymorphisms and lung cancer chemotherapy responseCollecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice.Annexin A4 reduces water and proton permeability of model membranes but does not alter aquaporin 2-mediated water transport in isolated endosomesPotential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout miceMetformin improves urine concentration in rodents with nephrogenic diabetes insipidus.Established and newly proposed mechanisms of chronic cyclosporine nephropathyCellular localization of adenine receptors in the rat kidney and their functional significance in the inner medullary collecting duct.A role for Wnt-4 in renal fibrosis.The protective effect of Nigella sativa against cisplatin-induced nephrotoxicity in ratsUse of sodium bicarbonate to promote weight gain, maintain body temperature, normalize renal functions and minimize mortality in rodents receiving the chemotherapeutic agent cisplatin.Effect of Dapagliflozin Treatment on Fluid and Electrolyte Balance in Diabetic Rats.Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins.Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling.P2Y2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations.Phosphatase inhibition increases AQP2 accumulation in the rat IMCD apical plasma membrane.Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney.Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis.P2Y2 receptor mRNA and protein expression is altered in inner medullas of hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function.Differential expression of aquaporins in the kidneys of streptozotocin-induced diabetic mice.Chronic dDAVP infusion in rats decreases the expression of P2Y2 receptor in inner medulla and P2Y2 receptor-mediated PGE2 release by IMCD.Automated method for the isolation of collecting ducts.Prognostic values of aquaporins mRNA expression in human ovarian cancer.Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice.Cisplatin decreases renal cyclooxygenase-2 expression and activity in rats.Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and ChallengesThe peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in miceEffect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicity
P2860
Q28566348-68B8B9FB-F471-488C-8FE2-ECCA689ABA0CQ33727799-E6C90A2C-16A8-46D1-9267-426EE97110E6Q34820718-7D91FD8C-3916-44D3-9FDF-E37057A71428Q35124361-82024B88-F64F-4B69-A96F-0E0D7C59A613Q35652098-E6391B41-38F8-46DD-858B-F5E0ADEDA324Q36412481-C5224DF6-9F51-4DD9-BCCF-31C133664680Q37018451-DF846C8F-66EA-47FD-919E-68B93EAC27D2Q37138664-B654580E-C567-4667-976D-BC3EB0DA6637Q37232923-B2652C2E-C29F-4004-B608-71F979DB182EQ37342017-271973E9-6BCB-4578-8966-0A5AE4015CF2Q40752346-BCC044A6-BE85-464B-86B9-620C1AEB3D17Q42133045-EAB83367-582F-43BB-8E0D-A2CFF1FD9E45Q42147217-E2967787-2F26-4E46-BA1A-64C9C90FB02CQ42763621-883B503A-4FD7-4578-BCCF-68B23F928A41Q44094428-A6327A21-CBBF-437E-BEC5-CCB21D329214Q44220589-D706253D-AB57-41BB-AF96-827B1FAFCFECQ44473606-2F6E95CD-82E9-446F-9767-A6197C185858Q44615866-9BBCE0EB-51E0-4FC9-B6D5-E42915E98100Q44761832-99C25050-A999-4952-92F4-07EF693814B2Q44876154-217D31E0-830D-41DF-8A2E-FA5ECF38F8E0Q45248570-2AB88711-EDBA-42C2-83B5-0DE64372DCCBQ45260688-F10405A4-11EE-4710-A41A-C6D9E4C476EFQ46508485-6F89FC33-6CDD-4C10-972A-99505F4B6AA8Q50740055-F817C716-5D5F-4AF1-BB69-11FEE93E50D4Q52689241-A6DBE934-5974-4435-891F-BD2252BAB008Q54284519-702479AB-D73E-43A0-8E44-78EE2F330353Q54390665-7E6CDB5D-461E-4CBA-97C5-249A147A35AEQ57112108-03D9FB67-858C-4FE6-8F0E-413C00C0A89DQ57212511-636E51CF-9319-4B7E-8BAA-F967CC699467Q57500197-98D80E7A-BE01-413C-B67A-37406E0F7B9A
P2860
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
@en
type
label
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
@en
prefLabel
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
@en
P2093
P1433
P1476
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
@en
P2093
P304
P356
10.1046/J.1523-1755.2000.00216.X
P407
P577
2000-08-01T00:00:00Z
P5875
P6179
1029987452